Clinical Trial Detail

NCT ID NCT02364999
Title A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC
Recruitment Completed
Gender
Phase Phase III
Variant Requirements Yes
Sponsors Pfizer
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab + Carboplatin + Paclitaxel

Age Groups:

Additional content available in CKB BOOST